Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer
- Sep 7, 2024
- 1 min read

Mistletoe extract (ME) is widely used for patients with cancer to support therapy and to improve quality of life (QoL). However, its use is controversial due to suboptimal trials and a lack of data supporting its intravenous administration.


Comments